Fig. 8: CpE@BMV enhances the pharmacokinetic profile of Cip. | Nature Communications

Fig. 8: CpE@BMV enhances the pharmacokinetic profile of Cip.

From: Bacterial membrane nanovesicles encapsulating prodrug assemblies combine chemical and immunological therapies for chronic bacterial infection

Fig. 8

a Cip concentration in plasma following peritoneal infection with either Cip or CpE@BMV at different time intervals. Data are presented as mean ± S.D. (n = 3 biological replicates). b Area under the curve calculated from (a). c Heatmap showing the Peak/MIC ratio of Cip and CpE@BMV against the various pathogens. d Heatmap showing the 24-h AUC/MIC ratio of Cip and CpE@BMV against the various pathogens.

Back to article page